PROMEDICA: Solutions for Innovative Medicine
Home ABOUT US
Home ABOUT US
Promedica Bioelectronics S.r.l. has over twenty-five years of experience in the field of marketing and technical management of high-technology equipment of Diagnostic Imaging and Oncology Therapy. Manages commercial strategic activities of multinational companies in the sector for the marketing of systems with MR-guided Focused Ultrasound (InSightec), of robotic systems for interventional radiology procedures (iSYS). Since 2013 Promedica produces and exports smart systems (Promedica Cabinet and Promedica Box) for the management and traceability of medical devices with RFID technology.
Recently Promedica entered the world of Research & Development creating a laboratory at the Giaccone Polyclinic in Palermo, aimed at the development of ultrasound equipment focused for drug delivery for small animals, both in the field of research that is preclinical. Finally Promedica markets the PRODUCTS of Millar Instruments.
Promedica proposes itself to clinical and research institutions as a provider of innovative technological solutions in the Diagnostic Imaging and Therapeutic sector. Promedica believes in a future of high instrumental technology for an early diagnosis of oncological and functional disabling diseases. Bets in a future of robotic and non-robotic equipment, strongly integrated into the hospital departments, and with the best health professionals, for the success of non-invasive therapies, in the superior respect of the quality of life of the patients. In fact, it has introduced innovative image-guided therapy technologies in Italy for the non-invasive treatment of benign and malignant lesions, helping to reduce the cost of hospitalization and the suffering of patients.
All Promedica staff has been trained with the passion of those who believe in a modern project of health ethics without compromise. Promedica also takes care of introducing new solutions for the optimal management of medical devices for the reduction of management costs. Promedica annually allocates important resources on research and development projects carried out jointly with Academic Institutions in Scientific Research, in vitro, preclinical and translational for the production of new teranostic technologies.